506181 Sigma-Aldrichp75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5 - Calbiochem
p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5, acts as an effective blocker of MAG- and Nogo-induced inhibition of neurite outgrowth in dorsal root ganglion & postnatal cerebellar neurons.
More>> p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5, acts as an effective blocker of MAG- and Nogo-induced inhibition of neurite outgrowth in dorsal root ganglion & postnatal cerebellar neurons. Less<<Synonyme: TAT-Pep5, H-YGRKKRRQRRR-CFFRGGFFNHNPRYC-OH, Cyclic
Empfohlene Produkte
Übersicht
| Replacement Information | 
|---|
Key Spec Table
| Empirical Formula | 
|---|
| C₁₅₀H₂₂₇N₅₇O₃₂S₂ | 
Preis & Verfügbarkeit
| Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
|---|---|---|---|---|---|---|
| 506181-500UG | 
 | Kst.-Ampulle | 500 μg | 
 | — | 
| Description | |
|---|---|
| Overview | The p75NTR inhibitor Pep5 (Cat. No. 506180) is made cell-permeable by fusing it with the N-terminal protein transduction domain sequence (11 amino acids) from HIV protein TAT. Shown to act as an effective blocker of MAG- and Nogo-induced inhibition of neurite outgrowth in both DRG (dorsal root ganglion) and postnatal cerebellar neurons. A potential therapeutic agent against inhibition of regeneration in the central nervous system. | 
| Catalogue Number | 506181 | 
| Brand Family | Calbiochem® | 
| Synonyms | TAT-Pep5, H-YGRKKRRQRRR-CFFRGGFFNHNPRYC-OH, Cyclic | 
| References | |
|---|---|
| References | Yamashita, T., and Tohyama, M. 2003. Nat. Neurosci. 6, 461. Schwarze, S.R., et al. 1999. Science 285, 1569. | 
| Product Information | |
|---|---|
| ATP Competitive | N | 
| Form | Lyophilized solid | 
| Formulation | Supplied as a trifluoroacetate salt. | 
| Hill Formula | C₁₅₀H₂₂₇N₅₇O₃₂S₂ | 
| Chemical formula | C₁₅₀H₂₂₇N₅₇O₃₂S₂ | 
| Hygroscopic | Hygroscopic | 
| Reversible | N | 
| Quality Level | MQ100 | 
| Biological Information | |
|---|---|
| Primary Target | Blocker of MAG- and Nogo-induced inhibition of neurite outgrowth | 
| Purity | ≥95% by HPLC | 
| Physicochemical Information | |
|---|---|
| Cell permeable | Y | 
| Peptide Sequence | H₂N-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Cys¹²-Phe-Phe-Arg-Gly-Gly-Phe-Phe-Asn-His-Asn-Pro-Arg-Tyr-Cys²⁶-OH disulfide bond (12-26) | 
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Product Usage Statements | 
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Bestellnummer | GTIN | 
| 506181-500UG | 04055977272413 | 
Documentation
p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5 - Calbiochem SDB
| Titel | 
|---|
p75NTR Signaling Inhibitor, Cell-permeable, TAT-Pep5 - Calbiochem Analysenzertifikate
| Titel | Chargennummer | 
|---|---|
| 506181 | 
Literatur
| Übersicht | 
|---|
| Yamashita, T., and Tohyama, M. 2003. Nat. Neurosci. 6, 461. Schwarze, S.R., et al. 1999. Science 285, 1569. | 

 


 
  

 

 
